Suzhou Chuanxuexi Bio-technology Co., Ltd. is committed to the full research of diabetes rehabilitation technology and the development of the whole industry chain, with its own research institute, medical experts team, industrial base, customer service center, operation center and network technology team. The company's research papers were published in the special issue of the 80th Annual Meeting of the American Diabetes Association (ADA). The company's two new drugs have been awarded two national invention patent applications, two patents have also been awarded the international PCT patent protection, is currently in the United States, the European Union, Japan and South Korea and other places to apply for patent registration.

Suzhou Chuanxuexi Biotechnology Co., Ltd, in recent years, through the dedicated research of traditional Chinese medicine, relying on big data innovation technology, the original diagnosis and rehabilitation of diabetes has a new understanding and enhancement, so that a large number of diabetic patients of the pancreatic islet function, insulin efficiency is restored, rehabilitation.